share_log

美诺华(603538.SH):子公司获得富马酸丙酚替诺福韦片药品注册证书

Menovar (603538.SH): The subsidiary obtained a drug registration certificate for propofovir fumarate tablets

Gelonghui Finance ·  Jul 8 04:53

Ningbo Menovo Pharmaceutical, a wholly-owned subsidiary of Menovo Pharmaceuticals (603538.SH), recently received the drug registration certificate for propofol disodium fosphenytoin/telbivudine tablets issued by the National Medical Products Administration. The drug is indicated for the treatment of chronic hepatitis B in adults and adolescents (aged 12 and above, weighing at least 35 kg).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment